Immunotherapy advances / (Record no. 20055)

MARC details
000 -LEADER
fixed length control field 01447nas a2200349 i 4500
001 - CONTROL NUMBER
control field EDZ0002387311
003 - CONTROL NUMBER IDENTIFIER
control field StDuBDS
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250228152236.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m||||fo||j||||||||
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr||||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201126c20209999enk|| p|o|||| 0 |2eng|d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2732-4303
040 ## - CATALOGING SOURCE
Original cataloging agency StDuBDS
Language of cataloging eng
Transcribing agency StDuBDS
Description conventions rda
-- pn
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM270
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.07905
Edition number 23
245 00 - TITLE STATEMENT
Title Immunotherapy advances /
Statement of responsibility, etc. editor-in-chief, Professor Tim Elliott, FRSB, FMedSci.
264 31 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Oxford :
Name of producer, publisher, distributor, manufacturer Oxford University Press,
Date of production, publication, distribution, manufacture, or copyright notice 2020-
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource
310 ## - CURRENT PUBLICATION FREQUENCY
Current publication frequency Frequency of update unknown
336 ## - CONTENT TYPE
Content type term text
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Source rdacarrier
362 1# - DATES OF PUBLICATION AND/OR SEQUENTIAL DESIGNATION
Dates of publication and/or sequential designation 2020-
500 ## - GENERAL NOTE
General note "British Society for Immunology"--Home page.
506 0# - RESTRICTIONS ON ACCESS NOTE
Terms governing access Open access.
520 8# - SUMMARY, ETC.
Summary, etc. 'Immunotherapy Advances' is a fully Open Access peer-reviewed journal brought to you by the British Society for Immunology and edited by world leading immunologist Professor Tim Elliott, supported by a global editorial board of experts from academia and industry.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on online resource; title from home page (viewed on November 26, 2020).
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunotherapy
General subdivision Research
Form subdivision Periodicals.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Elliott, Tim,
Relator term editor.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element British Society for Immunology,
Relator term associated with work.
856 40 - ELECTRONIC LOCATION AND ACCESS
Materials specified Oxford journals
Uniform Resource Identifier <a href="http://academic.oup.com/immunotherapyadv">http://academic.oup.com/immunotherapyadv</a>

No items available.

Designed & Maintained by: SRHU Library System
Central Library, Contact: